Indication
Immunological Tolerance
2 clinical trials
2 products
Clinical trial
A Single-armed, Unblinded, Non-randomized Feasibility Study of Hematopoietic Stem Cell Infusion Following a Conditioning Regimen of Total Lymphoid Irradiation (TLI) and Anti-thymocyte Globulin (ATG) in Patients With a Pre-existing, Well-functioning HLA-identical Kidney TransplantStatus: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
Use of the Immunomodulating Agent Belumosudil (KD025) After Combined Kidney and Hematopoeitic Stem Cell Transplantation to Induce Transplant Tolerance: A Pilot StudyStatus: Active (not recruiting), Estimated PCD: 2025-08-01